GLUD1 and colorectal carcinoma: CRC resistance to glucose deprivation correlates with GLUD1 and SLC25A13 (mitochondrial aspartate-glutamate carrier) levels, and their co-expression predicts aggressive phenotypes and poor prognosis (163).